Short answer
Humana (HUM) filed an 8-K current report with the SEC on April 10, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Board expansion from 10 to 11 directors, effective after the April 16, 2026 annual meeting.
Humana 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expansion from 10 to 11 directors, effective after the April 16, 2026 annual meeting
- Robert S. Field elected as an independent director under NYSE standards
- Restricted stock units granted under Humana’s director compensation program
- Committee assignments remain undecided
- No disclosed election arrangements or material related-party transactions
Item EX-99.1 · Exhibit EX-99.1
- Robert S. Field elected to Humana’s Board effective after the 2026 Annual Meeting
- Field brings more than two decades of healthcare investment experience, focused primarily on managed care
- Background includes Luxor Capital, McKinsey, and antitrust law, strengthening investment, strategy, and regulatory oversight
- Appointment follows shareholder engagement and supports ongoing Board refreshment and governance priorities
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Humana 8-K filings
Get the next HUM 8-K as it lands
Follow HUM for push alerts, or ask the research agent what this filing means.